Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-06 4:50 pm Purchase | 2025-06-04 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 11,899,788 22.400% | 1,214,898 (+11.37%) | Filing History |
| 2025-05-15 4:14 pm Purchase | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | Vestal Point Capital, LP | 2,879,829 5.400% | 2,879,829 (New Position) | Filing History |
| 2025-05-14 4:05 pm Purchase | 2025-05-07 | 13G | Tyra Biosciences, Inc. TYRA | Commodore Capital LP | 2,750,000 5.200% | 2,750,000 (New Position) | Filing History |
| 2025-05-14 11:47 am Purchase | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | JANUS HENDERSON GROUP PLC JHG | 2,693,237 5.100% | 2,693,237 (New Position) | Filing History |
| 2025-05-12 10:43 am Sale | 2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 1,707,148 3.200% | -1,665,702 (-49.39%) | Filing History |
| 2025-03-31 4:54 pm Purchase | 2025-03-27 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,684,890 20.100% | 7,750 (+0.07%) | Filing History |
| 2025-03-06 6:02 pm Purchase | 2025-02-27 | 13G | Tyra Biosciences, Inc. TYRA | TCG Crossover GP I, LLC | 2,898,103 5.700% | 2,898,103 (New Position) | Filing History |
| 2025-02-14 4:24 pm Sale | 2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 3,944,194 7.800% | -717,000 (-15.38%) | Filing History |
| 2025-01-21 4:30 pm Sale | 2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA | Canaan XI L.P. | 3,731,165 7.400% | -205,430 (-5.22%) | Filing History |
| 2024-12-06 9:30 pm Sale | 2024-12-04 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Asset Management Inc. | 2,548,905 5.000% | -1,522,949 (-37.40%) | Filing History |
| 2024-11-19 9:31 pm Sale | 2024-11-15 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Asset Management Inc. | 4,071,854 7.700% | -914,461 (-18.34%) | Filing History |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% | 1,537,279 (+61.04%) | Filing History |
| 2024-11-14 4:34 pm Purchase | 2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 4,661,194 8.800% | 1,921,599 (+70.14%) | Filing History |
| 2024-11-13 6:04 pm Purchase | 2024-11-08 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,677,140 21.100% | 586,069 (+5.81%) | Filing History |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 3,372,850 6.387% | -1,281,426 (-27.53%) | Filing History |
| 2024-10-22 9:15 pm Purchase | 2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Asset Management Inc. | 4,986,315 9.900% | 4,986,315 (New Position) | Filing History |
| 2024-10-22 5:11 pm Sale | 2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,091,071 19.990% | -384,418 (-3.67%) | Filing History |
| 2024-10-15 9:59 pm Purchase | 2024-10-10 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,534,298 12.400% | 85,939 (+1.33%) | Filing History |
| 2024-10-15 7:22 pm Unchanged | 2024-10-10 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Asset Management Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-03-11 08:19 am Purchase | 2024-03-08 | 13G | Tyra Biosciences, Inc. TYRA | FMR LLC | 4,654,276 10.809% | 1,885,580 (+68.10%) | Filing History |